Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
AlHussaini Frontiers in Medicine .2026;[Epub] CrossRef Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with Extrahepatic Cancers and Sarcopenia Yusuf Yilmaz, Alina M
The 2025 EULAR recommendations for SLE with kidney involvement now acknowledge that EAS-guided prescriptions of GLP-1 receptor agonists could reduce the burden of cardiovascular disease in SLE populations
Many patients pay for GLP-1 medications out of pocket and may resist paying extra for aftercare
Once hailed solely as a game-changer in weight loss and diabetes management, GLP-1 drugs like Ozempic, Wegovy, and Zepbound are now generating buzz for a much broader range of potential health benefits
The April 2025 JAMA Psychiatry trial specifically evaluated semaglutide in alcohol use disorder, providing prospective clinical data supporting its potential in this indication
US$ 21.56
US$ 27.21
US$ 20.30
